In a Russia.

The Russian equivalent of FDA approval is anticipated to occur within the next two weeks for a COVID-19 vaccine developed by a state-owned Moscow research institute, preliminarily tested on soldier “volunteers” with post-approval plans for voluntary vaccination of Russian healthcare workers. | Grove, Wall Street Journal 2020


Popular Posts